Fischer, M Dominik <br/><br/>
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.  [electronic resource] 

 -  JAMA ophthalmology  06 2020 
 - 643-651 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6173 
<br/><br/><label>Standard No.: </label>10.1001/jamaophthalmol.2020.1032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Color Vision Defects--diagnosis<br/>Cyclic Nucleotide-Gated Cation Channels--genetics<br/>Electroretinography<br/>Female<br/>Follow-Up Studies<br/>Genetic Therapy--methods<br/>Humans<br/>Male<br/>Middle Aged<br/>Retina<br/>Retinal Cone Photoreceptor Cells--pathology<br/>Retrospective Studies<br/>Treatment Outcome<br/>Visual Acuity<br/>Young Adult